Correspondence 533 Thirdly, Naccarato et al.  pointed out that, according to & Dome (MSD), Janssen-Cilag, Bristol Myers Squibb, their single-case experience, the combination of dolute- Boehringer Ingelheim, ViiVand Abbvie. C.R. declare no gravir and metformin should be avoided in elderly conﬂict of interest. All Authors have read and approved patients with sub-optimal renal function. However, the text. looking at their Table 1, the patient had serum creatinine concentrations ranging from 65 to 70mmol/l (0.7– Conﬂicts of interest 0.8 mg/L), thus hardly reﬂecting the presence of a There are no conﬂicts of interest. clinically relevant kidney dysfunction. Remarkably, three out of the 15 patients in our cohort who are more than 65 a,b c Dario Cattaneo , Chiara Resnati , Giuliano Rizzar- c,d b,c a years old and with serum creatinine concentrations dini and Cristina Gervasoni , Unit of Clinical ranging from 83 to 143mmol/l (0.9–1.63 mg/l) showed Pharmacology, ASST Fatebenefratelli Sacco University an optimal tolerability to dolutegravir with metformin Hospital, Gestione Ambulatoriale Politerapie (GAP) therapy. These results are in line with those by Masich Outpatient Clinic, ASST Fatebenefratelli Sacco, et al.  reporting no cases of lactic acidosis in patients Department of Infectious Diseases, ASST Fatebenefra- telli Sacco
AIDS – Wolters Kluwer Health
Published: Feb 20, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera